Royce & Associates’s Acorda Therapeutics ACOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-107
Closed -$9K 1081
2020
Q4
$9K Sell
107
-44
-29% -$4.05K ﹤0.01% 996
2020
Q3
$9K Hold
151
﹤0.01% 989
2020
Q2
$13K Hold
151
﹤0.01% 1127
2020
Q1
$17K Sell
151
-61
-29% -$12K ﹤0.01% 1105
2019
Q4
$52K Hold
212
﹤0.01% 1036
2019
Q3
$73K Buy
212
+11
+5% +$5.98K ﹤0.01% 1016
2019
Q2
$185K Buy
201
+181
+905% +$222K ﹤0.01% 994
2019
Q1
$32K Buy
20
+6
+43% +$10.8K ﹤0.01% 1082
2018
Q4
$26K Buy
14
+1
+8% +$2.18K ﹤0.01% 1068
2018
Q3
$32K Buy
13
+8
+160% +$24.8K ﹤0.01% 1087
2018
Q2
$16K Buy
5
+2
+67% +$6.12K ﹤0.01% 1170
2018
Q1
$10K Buy
+3
New +$8.98K ﹤0.01% 1186

Other funds holding ACOR